Stock Movers Nvidia Outperforms; Avidity Biosciences Rallies; Carter's Falls
5 snips
Oct 27, 2025 Nvidia is leading a rally among tech stocks as optimism grows over a potential U.S.-China trade deal. Avidity Biosciences sees its shares soar after Novartis announces a massive $12 billion acquisition, marking a significant move in the biotech space. On the flip side, Carter's is struggling, reporting disappointing sales and planning to cut jobs and close more stores. The hosts delve into these market dynamics, providing insight into the factors shaping today's financial landscape.
AI Snips
Chapters
Transcript
Episode notes
Trade Optimism Lifts Tech Stocks
- Nvidia and the broader Magnificent Seven rose on optimism around U.S.-China trade talks that could ease tech tensions.
- Improved bilateral relations may indirectly unlock semiconductor trade progress even without direct mentions of chips.
Policy News Hits Rare-Earth Miners
- Rare-earth miners fell after a report that export control delays for China could be extended by a year.
- That policy development pressured stocks like MP Materials and Critical Metals ahead of further clarity.
Novartis Acquires Avidity For $12B
- Avidity Biosciences jumped about 44% after Novartis agreed to buy the company for $72 a share in a roughly $12 billion deal.
- The acquisition represents Novartis's largest purchase in over a decade and boosts its experimental rare-disease pipeline.